Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT02893163Not ApplicableCompleted

CHANGE Cancer Alberta: A Primary Care Program for Cancer Prevention and Screening

Role: collaborator

NCT02370927Not ApplicableCompleted

PERFECT Project - Part 2 - Study 2

Role: collaborator

NCT02365363Not ApplicableCompleted

PERFECT Project - Part 2 - Study 3

Role: collaborator

NCT02402504Not ApplicableCompleted

PERFECT Project - Part 1 - Study 1

Role: collaborator

NCT02385890Not ApplicableCompleted

PERFECT Project - Part 1 - Study 3

Role: collaborator

NCT02366572Not ApplicableCompleted

PERFECT Project - Part 1 - Study 2

Role: collaborator

NCT02402517Not ApplicableCompleted

PERFECT Project - Part 2 - Study 1

Role: collaborator

NCT01719900Not ApplicableCompleted

Evaluation of Pulse Fibre Supplementation on Obesity and the Metabolic Syndrome

Role: collaborator

All 8 trials loaded